Taiwan–Vietnam Research and Development Partnership for Agricultural Biotechnology Innovation
Our Center’s Academician Shyi-Dong Yeh has positioned Vietnam as a core demonstration site for his papaya agricultural biotechnology R&D achievements. Through licensing and industrial-scale demonstration of key papaya technologies, this initiative establishes a replicable Taiwan–Vietnam collaboration model to drive Taiwan’s agricultural biotechnology technology transfer and global outreach. It will not only catalyze additional cross-border collaborative programs, but also help build an internationally competitive papaya brand.
AI-Driven Orchid Phenotyping to Build a Next-Generation Smart Breeding Platform
Our Center’s Associate Professor Li-Ching Hsieh has developed an orchid image feature recognition system that focuses on image-based phenotypic analysis of Phalaenopsis orchids. Using image recognition technologies, the system precisely characterizes floral structure and color traits. It can segment a Phalaenopsis flower into distinct parts—including the petals, dorsal sepal, lateral sepals, and labellum (lip)—and identify key traits for each part, such as spots, stripes, reticulate patterns, and the dominant color.
Users simply upload a newly captured Phalaenopsis image to quickly obtain up to 17 phenotypic trait outputs, providing an efficient and scalable technical platform for orchid cultivar identification, breeding research, and smart agriculture applications.
Technology Transfer of Polyclonal and Monoclonal Antibodies for Orchid Virus Detection
Our Center’s Professor Fuh-Jyh Jan transferred two orchid virus detection antibodies, including polyclonal and monoclonal antibodies, to Easyget Life Sciences Co., Ltd. for the development and commercialization of rapid orchid virus diagnostic kits.
Collaboration with Medical Centers to Expand Research Capacity
Our Center’s Professor Hui-Chih Hung collaborates with Chung Shan Medical University to investigate the protective mechanisms of denosumab against glucolipotoxicity-induced ectopic lipid accumulation and apoptosis in pancreatic β cells. This work aims to clarify the role of denosumab in β-cell lipid deposition and will support the future development of novel therapeutic or preventive strategies for type 2 diabetes (T2D).